» Articles » PMID: 19875682

Lung Pathology in Fatal Novel Human Influenza A (H1N1) Infection

Abstract

Rationale: There are no reports of the systemic human pathology of the novel swine H1N1 influenza (S-OIV) infection.

Objectives: The autopsy findings of 21 Brazilian patients with confirmed S-OIV infection are presented. These patients died in the winter of the southern hemisphere 2009 pandemic, with acute respiratory failure.

Methods: Lung tissue was submitted to virologic and bacteriologic analysis with real-time reverse transcriptase polymerase chain reaction and electron microscopy. Expression of toll-like receptor (TLR)-3, IFN-gamma, tumor necrosis factor-alpha, CD8(+) T cells and granzyme B(+) cells in the lungs was investigated by immunohistochemistry.

Measurements And Main Results: Patients were aged from 1 to 68 years (72% between 30 and 59 yr) and 12 were male. Sixteen patients had preexisting medical conditions. Diffuse alveolar damage was present in 20 individuals. In six patients, diffuse alveolar damage was associated with necrotizing bronchiolitis and in five with extensive hemorrhage. There was also a cytopathic effect in the bronchial and alveolar epithelial cells, as well as necrosis, epithelial hyperplasia, and squamous metaplasia of the large airways. There was marked expression of TLR-3 and IFN-gamma and a large number of CD8(+) T cells and granzyme B(+) cells within the lung tissue. Changes in other organs were mainly secondary to multiple organ failure.

Conclusions: Autopsies have shown that the main pathological changes associated with S-OIV infection are localized to the lungs, where three distinct histological patterns can be identified. We also show evidence of ongoing pulmonary aberrant immune response. Our results reinforce the usefulness of autopsy in increasing the understanding of the novel human influenza A (H1N1) infection.

Citing Articles

Uncovering the Mechanisms of BaBaoWuDanYaoMo Against Influenza A Virus and Virus-Induced Inflammation Based on Network Pharmacology and Pharmacological Evaluation.

Lei B, Su Y, Chen R, Chen Z, Liu B, Chen Y Infect Drug Resist. 2025; 18:567-587.

PMID: 39902273 PMC: 11789520. DOI: 10.2147/IDR.S491101.


Molecular characterisation of influenza B virus from the 2017/18 season in primary models of the human lung reveals improved adaptation to the lower respiratory tract.

Caliskan D, Kumar S, Hinse S, Schughart K, Wiewrodt R, Fischer S Emerg Microbes Infect. 2024; 13(1):2402868.

PMID: 39248230 PMC: 11421153. DOI: 10.1080/22221751.2024.2402868.


The frequency and function of nucleoprotein-specific CD8 T cells are critical for heterosubtypic immunity against influenza virus infection.

Amoah S, Cao W, Sayedahmed E, Wang Y, Kumar A, Mishina M J Virol. 2024; 98(8):e0071124.

PMID: 39082839 PMC: 11334528. DOI: 10.1128/jvi.00711-24.


Recent Insights into the Molecular Mechanisms of the Toll-like Receptor Response to Influenza Virus Infection.

Kayesh M, Kohara M, Tsukiyama-Kohara K Int J Mol Sci. 2024; 25(11).

PMID: 38892096 PMC: 11172706. DOI: 10.3390/ijms25115909.


Clinical characteristics and assessment of risk factors in patients with influenza A-induced severe pneumonia after the prevalence of SARS-CoV-2.

Ma Y, Gao Q Open Med (Wars). 2024; 19(1):20240953.

PMID: 38633219 PMC: 11022039. DOI: 10.1515/med-2024-0953.